Brain Cancer Diagnostics Market, Global Outlook and Forecast 2023-2028

Report ID: 1314507 | Published Date: Jan 2025 | No. of Page: 61 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Brain Cancer Diagnostics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Brain Cancer Diagnostics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Brain Cancer Diagnostics Overall Market Size
    2.1 Global Brain Cancer Diagnostics Market Size: 2021 VS 2028
    2.2 Global Brain Cancer Diagnostics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Brain Cancer Diagnostics Players in Global Market
    3.2 Top Global Brain Cancer Diagnostics Companies Ranked by Revenue
    3.3 Global Brain Cancer Diagnostics Revenue by Companies
    3.4 Top 3 and Top 5 Brain Cancer Diagnostics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Brain Cancer Diagnostics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Brain Cancer Diagnostics Players in Global Market
        3.6.1 List of Global Tier 1 Brain Cancer Diagnostics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Brain Cancer Diagnostics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Brain Cancer Diagnostics Market Size Markets, 2021 & 2028
        4.1.2 Imaging Test
        4.1.3 Lumbar Puncture
        4.1.4 Biopsy
        4.1.5 Molecular Testing
        4.1.6 Others
    4.2 By Type - Global Brain Cancer Diagnostics Revenue & Forecasts
        4.2.1 By Type - Global Brain Cancer Diagnostics Revenue, 2017-2022
        4.2.2 By Type - Global Brain Cancer Diagnostics Revenue, 2023-2028
        4.2.3 By Type - Global Brain Cancer Diagnostics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Brain Cancer Diagnostics Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Specialty Clinics
        5.1.4 Others
    5.2 By Application - Global Brain Cancer Diagnostics Revenue & Forecasts
        5.2.1 By Application - Global Brain Cancer Diagnostics Revenue, 2017-2022
        5.2.2 By Application - Global Brain Cancer Diagnostics Revenue, 2023-2028
        5.2.3 By Application - Global Brain Cancer Diagnostics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Brain Cancer Diagnostics Market Size, 2021 & 2028
    6.2 By Region - Global Brain Cancer Diagnostics Revenue & Forecasts
        6.2.1 By Region - Global Brain Cancer Diagnostics Revenue, 2017-2022
        6.2.2 By Region - Global Brain Cancer Diagnostics Revenue, 2023-2028
        6.2.3 By Region - Global Brain Cancer Diagnostics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Brain Cancer Diagnostics Revenue, 2017-2028
        6.3.2 US Brain Cancer Diagnostics Market Size, 2017-2028
        6.3.3 Canada Brain Cancer Diagnostics Market Size, 2017-2028
        6.3.4 Mexico Brain Cancer Diagnostics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Brain Cancer Diagnostics Revenue, 2017-2028
        6.4.2 Germany Brain Cancer Diagnostics Market Size, 2017-2028
        6.4.3 France Brain Cancer Diagnostics Market Size, 2017-2028
        6.4.4 U.K. Brain Cancer Diagnostics Market Size, 2017-2028
        6.4.5 Italy Brain Cancer Diagnostics Market Size, 2017-2028
        6.4.6 Russia Brain Cancer Diagnostics Market Size, 2017-2028
        6.4.7 Nordic Countries Brain Cancer Diagnostics Market Size, 2017-2028
        6.4.8 Benelux Brain Cancer Diagnostics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Brain Cancer Diagnostics Revenue, 2017-2028
        6.5.2 China Brain Cancer Diagnostics Market Size, 2017-2028
        6.5.3 Japan Brain Cancer Diagnostics Market Size, 2017-2028
        6.5.4 South Korea Brain Cancer Diagnostics Market Size, 2017-2028
        6.5.5 Southeast Asia Brain Cancer Diagnostics Market Size, 2017-2028
        6.5.6 India Brain Cancer Diagnostics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Brain Cancer Diagnostics Revenue, 2017-2028
        6.6.2 Brazil Brain Cancer Diagnostics Market Size, 2017-2028
        6.6.3 Argentina Brain Cancer Diagnostics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Brain Cancer Diagnostics Revenue, 2017-2028
        6.7.2 Turkey Brain Cancer Diagnostics Market Size, 2017-2028
        6.7.3 Israel Brain Cancer Diagnostics Market Size, 2017-2028
        6.7.4 Saudi Arabia Brain Cancer Diagnostics Market Size, 2017-2028
        6.7.5 UAE Brain Cancer Diagnostics Market Size, 2017-2028
7 Players Profiles
    7.1 Thermo Fisher Scientific Inc.
        7.1.1 Thermo Fisher Scientific Inc. Corporate Summary
        7.1.2 Thermo Fisher Scientific Inc. Business Overview
        7.1.3 Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Major Product Offerings
        7.1.4 Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Revenue in Global Market (2017-2022)
        7.1.5 Thermo Fisher Scientific Inc. Key News
    7.2 Siemens Healthineers AG
        7.2.1 Siemens Healthineers AG Corporate Summary
        7.2.2 Siemens Healthineers AG Business Overview
        7.2.3 Siemens Healthineers AG Brain Cancer Diagnostics Major Product Offerings
        7.2.4 Siemens Healthineers AG Brain Cancer Diagnostics Revenue in Global Market (2017-2022)
        7.2.5 Siemens Healthineers AG Key News
    7.3 GE Healthcare
        7.3.1 GE Healthcare Corporate Summary
        7.3.2 GE Healthcare Business Overview
        7.3.3 GE Healthcare Brain Cancer Diagnostics Major Product Offerings
        7.3.4 GE Healthcare Brain Cancer Diagnostics Revenue in Global Market (2017-2022)
        7.3.5 GE Healthcare Key News
    7.4 MDxHealth
        7.4.1 MDxHealth Corporate Summary
        7.4.2 MDxHealth Business Overview
        7.4.3 MDxHealth Brain Cancer Diagnostics Major Product Offerings
        7.4.4 MDxHealth Brain Cancer Diagnostics Revenue in Global Market (2017-2022)
        7.4.5 MDxHealth Key News
    7.5 NantOmics
        7.5.1 NantOmics Corporate Summary
        7.5.2 NantOmics Business Overview
        7.5.3 NantOmics Brain Cancer Diagnostics Major Product Offerings
        7.5.4 NantOmics Brain Cancer Diagnostics Revenue in Global Market (2017-2022)
        7.5.5 NantOmics Key News
    7.6 Biocept, Inc.
        7.6.1 Biocept, Inc. Corporate Summary
        7.6.2 Biocept, Inc. Business Overview
        7.6.3 Biocept, Inc. Brain Cancer Diagnostics Major Product Offerings
        7.6.4 Biocept, Inc. Brain Cancer Diagnostics Revenue in Global Market (2017-2022)
        7.6.5 Biocept, Inc. Key News
    7.7 Koninklijke Philips N.V.
        7.7.1 Koninklijke Philips N.V. Corporate Summary
        7.7.2 Koninklijke Philips N.V. Business Overview
        7.7.3 Koninklijke Philips N.V. Brain Cancer Diagnostics Major Product Offerings
        7.7.4 Koninklijke Philips N.V. Brain Cancer Diagnostics Revenue in Global Market (2017-2022)
        7.7.5 Koninklijke Philips N.V. Key News
    7.8 Canon Medical Systems
        7.8.1 Canon Medical Systems Corporate Summary
        7.8.2 Canon Medical Systems Business Overview
        7.8.3 Canon Medical Systems Brain Cancer Diagnostics Major Product Offerings
        7.8.4 Canon Medical Systems Brain Cancer Diagnostics Revenue in Global Market (2017-2022)
        7.8.5 Canon Medical Systems Key News
    7.9 Hitachi, Ltd.
        7.9.1 Hitachi, Ltd. Corporate Summary
        7.9.2 Hitachi, Ltd. Business Overview
        7.9.3 Hitachi, Ltd. Brain Cancer Diagnostics Major Product Offerings
        7.9.4 Hitachi, Ltd. Brain Cancer Diagnostics Revenue in Global Market (2017-2022)
        7.9.5 Hitachi, Ltd. Key News
    7.10 Neusoft Medical Systems
        7.10.1 Neusoft Medical Systems Corporate Summary
        7.10.2 Neusoft Medical Systems Business Overview
        7.10.3 Neusoft Medical Systems Brain Cancer Diagnostics Major Product Offerings
        7.10.4 Neusoft Medical Systems Brain Cancer Diagnostics Revenue in Global Market (2017-2022)
        7.10.5 Neusoft Medical Systems Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Brain Cancer Diagnostics Market Opportunities & Trends in Global Market
    Table 2. Brain Cancer Diagnostics Market Drivers in Global Market
    Table 3. Brain Cancer Diagnostics Market Restraints in Global Market
    Table 4. Key Players of Brain Cancer Diagnostics in Global Market
    Table 5. Top Brain Cancer Diagnostics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Brain Cancer Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Brain Cancer Diagnostics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Brain Cancer Diagnostics Product Type
    Table 9. List of Global Tier 1 Brain Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Brain Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Brain Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Brain Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Brain Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Brain Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Brain Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Brain Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Brain Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Brain Cancer Diagnostics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Brain Cancer Diagnostics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Brain Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Brain Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Brain Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Brain Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Brain Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 30. Thermo Fisher Scientific Inc. Corporate Summary
    Table 31. Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Product Offerings
    Table 32. Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 33. Siemens Healthineers AG Corporate Summary
    Table 34. Siemens Healthineers AG Brain Cancer Diagnostics Product Offerings
    Table 35. Siemens Healthineers AG Brain Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 36. GE Healthcare Corporate Summary
    Table 37. GE Healthcare Brain Cancer Diagnostics Product Offerings
    Table 38. GE Healthcare Brain Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 39. MDxHealth Corporate Summary
    Table 40. MDxHealth Brain Cancer Diagnostics Product Offerings
    Table 41. MDxHealth Brain Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 42. NantOmics Corporate Summary
    Table 43. NantOmics Brain Cancer Diagnostics Product Offerings
    Table 44. NantOmics Brain Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 45. Biocept, Inc. Corporate Summary
    Table 46. Biocept, Inc. Brain Cancer Diagnostics Product Offerings
    Table 47. Biocept, Inc. Brain Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 48. Koninklijke Philips N.V. Corporate Summary
    Table 49. Koninklijke Philips N.V. Brain Cancer Diagnostics Product Offerings
    Table 50. Koninklijke Philips N.V. Brain Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 51. Canon Medical Systems Corporate Summary
    Table 52. Canon Medical Systems Brain Cancer Diagnostics Product Offerings
    Table 53. Canon Medical Systems Brain Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 54. Hitachi, Ltd. Corporate Summary
    Table 55. Hitachi, Ltd. Brain Cancer Diagnostics Product Offerings
    Table 56. Hitachi, Ltd. Brain Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 57. Neusoft Medical Systems Corporate Summary
    Table 58. Neusoft Medical Systems Brain Cancer Diagnostics Product Offerings
    Table 59. Neusoft Medical Systems Brain Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Brain Cancer Diagnostics Segment by Type in 2021
    Figure 2. Brain Cancer Diagnostics Segment by Application in 2021
    Figure 3. Global Brain Cancer Diagnostics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Brain Cancer Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Brain Cancer Diagnostics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Brain Cancer Diagnostics Revenue in 2021
    Figure 8. By Type - Global Brain Cancer Diagnostics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Brain Cancer Diagnostics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Brain Cancer Diagnostics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Brain Cancer Diagnostics Revenue Market Share, 2017-2028
    Figure 12. US Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Brain Cancer Diagnostics Revenue Market Share, 2017-2028
    Figure 16. Germany Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Brain Cancer Diagnostics Revenue Market Share, 2017-2028
    Figure 24. China Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Brain Cancer Diagnostics Revenue Market Share, 2017-2028
    Figure 30. Brazil Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Brain Cancer Diagnostics Revenue Market Share, 2017-2028
    Figure 33. Turkey Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Brain Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 37. Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Siemens Healthineers AG Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. GE Healthcare Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. MDxHealth Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. NantOmics Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Biocept, Inc. Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Koninklijke Philips N.V. Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Canon Medical Systems Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Hitachi, Ltd. Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Neusoft Medical Systems Brain Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
61
Frequently Asked Questions
Brain Cancer Diagnostics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Brain Cancer Diagnostics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Brain Cancer Diagnostics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pediatric MRI Market

Pediatric magnetic resonance imaging (MRI) uses a magnetic field, radio waves, and a computer to  ... Read More